Transcat, Inc.

NASDAQ:TRNS

Industrial - Distribution

Industrials
$100.12 +2.19%

+$2.00 today

Market cap
$941.61M
Beta
0.70
P/E (TTM)
150.2
EPS (TTM)
$0.62
52W Low $50.23High $94.76

Volume 0.11M

Average 0.16M

TRNS EBITDA Margin

EBITDA as a percentage of revenue.

Transcat, Inc.NASDAQ: TRNS

EBITDA Margin · Q3 FY2026 · quarter ended Dec 2025

EBITDA Margin widens to 13.2%

EBITDA Margin was 13.2% in Q3 FY2026, up 1.2 pp from a year earlier. On a trailing-twelve-month basis it was 12.2%, down 1.4 pp year over year. Over 3 fiscal years it widened by 0.0 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 14.0% for the fiscal year ending Mar 2027, up from 11.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
13.2%+1.3 pp QoQ
Last fiscal yearMar 2026
11.7%-1.9 pp YoY
LTMMar 2026
12.2%-1.4 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.2 pp+1.1 pp-0.1 pp
1 year-1.9 pp+2.4 pp+4.2 pp
3 years+0.0 pp+1.9 pp+1.9 pp
5 years+2.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
11.7%
Year-over-year change
-1.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How TRNS compares with its peers on the latest reported figures

  • TRNS's LTM Mar 2026 EBITDA Margin of 12.2% is the 5th highest of the 11 companies compared; the peer median is 6.2%.
  • Its year-over-year change of -1.4 pp is the 7th highest of 11, against a peer median of -0.4 pp.
  • Over three fiscal years its change of +0.0 pp compares with a peer median of +5.1 pp.
TRNS Competitors Peer median
EBITDA Margin for TRNS and competitors
Company Period LTM level YoY 3-year change
MTDMettler-Toledo International Inc.LTM Jun 202631.6% +0.0 pp-0.7 pp
TECHBio-Techne CorporationLTM Sep 202626.8% +8.6 pp-11.9 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202619.9% -6.2 pp+208.5 pp
UFPTUFP Technologies, Inc.LTM Jun 202618.4% -0.8 pp-0.5 pp
TRNSTranscat, Inc.LTM Mar 202612.2% -1.4 pp+0.0 pp
TICTIC Solutions, Inc.LTM Jun 202610.6% +3.1 pp-3.5 pp
NEONeoGenomics, Inc.LTM Jun 20261.7% +5.8 pp+10.8 pp
BLFSBioLife Solutions, Inc.LTM Mar 2026-7.5% -19.9 pp+166.6 pp
QDELQuidelOrtho CorporationLTM Mar 2026-20.7% -31.1 pp-51.4 pp
TKNOAlpha Teknova, Inc.LTM Mar 2026-23.8% +18.3 pp+37.0 pp
LABStandard BioTools Inc.LTM Mar 2026-94.5% -30.2 pp+72.1 pp
Peer median (excluding TRNS) 6.2%-0.4 pp+5.1 pp

Competitors are the stored peer set for TRNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue204.96M230.57M259.48M278.42M331.88M
Cost of Revenue146.52M162.21M175.68M188.97M223.57M
Gross Profit58.44M68.36M83.81M89.45M108.3M
Gross Margin28.5%29.6%32.3%32.1%32.6%
Research & Development00000
Selling, General & Admin44.3M52.11M64.03M71.58M95.04M
Operating Expenses44.3M52.11M64.03M71.58M95.04M
Depreciation & Amortization9.57M10.96M13.54M18.57M26.17M
EBITDA23.57M26.86M33.82M37.69M38.76M
EBITDA Margin11.5%11.6%13.0%13.5%11.7%
Operating Income14.14M16.25M19.78M17.87M13.26M
Operating Margin6.9%7.0%7.6%6.4%4.0%
Interest Income00808K825K0
Interest Expense810K2.42M1.84M798K5.27M
Other Income / Expenses(953K)(2.76M)(1.34M)452K(5.27M)
Income Before Tax13.19M13.49M18.44M18.33M7.99M
Pre-Tax Margin6.4%5.8%7.1%6.6%2.4%
Income Tax Expense1.81M2.8M4.79M3.81M2.61M
Net Income11.38M10.69M13.65M14.52M5.38M
Net Margin5.6%4.6%5.3%5.2%1.6%
EPS (Basic)1.521.421.661.580.58
EPS (Diluted)1.501.401.631.570.57
Weighted Avg Shares7.5M7.55M8.24M9.19M9.33M
Weighted Avg Shares (Diluted)7.59M7.65M8.35M9.25M9.33M

Transcat, Inc.

NASDAQ:TRNS

Intrinsic Alpha fair value

Locked

Current Price

$100.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.